-
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of "Moderate Buy" from Analysts
Source: Buzz FX / 25 Dec 2024 01:49:11 America/Chicago
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat December 25, 2024 Share Link copied to clipboard. Beam Therapeutics Inc. ( NASDAQ:BEAM - Get Free Report ) has receiv
Read more...